Beruflich Dokumente
Kultur Dokumente
OUTLINE
INTRODUCTION INITIATION OF THERAPY PRINCIPLE OF RRT RRT TECHNIQUES AND ITS INDICATION PROS AND CONS COMPLICATIONS OCCURS IN CRRT COMPARISON BTW IHD AND CRRT
INTRODUCTION
When ARF is severe, resolution may take several days or weeks During this time, the kidneys cannot maintain homeostasis of fluid, K+ , metabolic acid and waste products in which some may respond to medical measure and some may not. Those who are not responsive to medical measure, acute renal replacement therapy (ARRT) is vital.
Initiation of Therapy
RIFLE Criteria
Level of injury
Outcome measures
Stage 1 Stage 2
2-3 folds
Stage 3
or urine output Patients receiving RRT are Stage 3 regardless of urine output
Modification of the RIFLE criteria by Acute Kidney Injury Network Both diagnostic and staging system Diagnostic criteria
abrupt in onset within 48 hrs Absolute increase in serum Cr >=0.3mg/dL or 26.4 mmol/L or % increase of Cr >=50% or oliguric for >=6 hrs After volume status optimised and urinary tract obstruction excluded
Staging system
RIFLE Loss and ESRF are removed
Target n RRT
Current targets include:
Reduction of urea >65-70% Kt/Vd is above 1.3 CRRT at urea clearance of 35 40l/day
PRINCIPLE OF RRT
PRINCIPLE OF RRT
DIFFUSION (HEMODIALYSIS) CONVECTION (HEMOFILTRATION) ULTRAFILTRATION(ALL THERAPIES) DIFFUSION AND CONVECTION (HEMODIAFILTRATION)
DIFFUSION
is the movement of solutes from a higher to a lower solute concentration area. Efficient in removing small molecules (<500d) but not large molecules is the main determinant of solute removal during dialysis
Dialysis (....diffusion)
Solutes flow down an electrochemical gradient, across a membrane. Solute removal is proportional to dialysate flow rate Dialysate flows counter-current to blood
Dialysate
is the fluid that is pumped into the filter canister, surrounding the hollow fibers The concentration of solutes in the dialysis fluid determines diffusion gradients The removal of surplus solutes from the blood is achieved by infusing dialysate fluid that contains a lower solute concentration than the serum concentration Eg: in renal failure, K+ is often high . Thus, may start with low K+ in the dialysate. Thus, there will be diffusion from high concentration (pts blood) to the low concentration(dialysate) in order to remove K+ fr pts blood.
Dialysate
Eg: in renal failure, HCO3 is low. So, HCO3 is added to dialysate to facilitate diffusion from high concentration( dialysate) to low concentration(pts blood)
Dialysate
The main composition are sodium chloride, sodium bicarbonate or sodium acetate, calcium chloride, potassium chloride, and magnesium chloride Thus, it is used to replace electrolytes
CONVECTION
Is a one-way movement of solutes through a semipermeable membrane with a water flow. Sometimes it is referred to as solvent drag. (Water movement
drags solute across membrane)
Efficient in removing larger and smaller molecules The faster the substitution flow rate, the higher the clearance The ultrafiltratecontaining the solute should be replaced by substitution solutions Main principle for hemofiltration
Convection
ULTRAFILTRATION
Is the movement of fluid through a semipermeable membrane along a pressure gradient The ultrafiltration rate depends on the pressure applied to the filter, inside and outside the fibers It removes fluid
306100135
RRT techniques
IHD
Intermittent haemodialysis
SLEDD
Sustained (or slow) low efficiency daily dialysis
CVVH
Continuous veno-venous haemofiltration
IUF
Isolated Ultrafiltration
SLEDD-F
Sustained (or slow) low efficiency daily dialysis with filtration
CVVHD
Continuous veno-venous haemodialysis
CVVHDF
Continuous veno-venous haemodiafiltration
SCUF
Slow continuous ultrafiltration
Anatomy of a Hemofilter
blood in
dialysate out Cross Section hollow fiber membrane
dialysate in
blood out
The blood flows in one direction and the dialysate flows in the opposite
306100135
Semi-permeable Membrane
The semi-permeable membrane provides: An interface between the blood and dialysate compartment. Biocompatibility minimizes: Severe patient reactions Decreases the complement activation
306100135
CVVH
INTERMITTENT HEMODIALYSIS
INTERMITTENT HEMODIALYSIS
Technically similar to what ESRF pt on chronic HD undergo in the community dialysis centres. Uses high dialysate flows (300-400ml/min) and short period of time ( 3-4 hrs)
IHD
Medical requirements and indication:
Hemodynamically stable ( no more than 1 vasopressor agent at low doses preferably) Vascular access: AVF or temporary dual lumen veno-venous dialysis catheter Relative C/I in high ICP as IHD may increase brain water content ( cerebral edema)
Cerebral oedema
Gut/coronary ischaemia
SLED
SLED
More gentle form / hybrid technology of IHD Lower Qb (150-200ml/min) and lower Qd (100-300ml/min)
SLED
Indication:
Recent ACS , AMI and severe cardiac failure with low vent ejection fraction Unstable BP requiring at most one vasopressor agent As a prelude to IHD following recovery from major critical illness during CRRT was utilized Recent worsening in overall condition resulting in IHD being poorly tolerated and pt become frankly hypotensive but still maintain SBP>100 with low dose of a single inotropes
CRRT
Preferred dialytic modality in critically ill, hypercatabolic pt with unstable circulatory state ( with high doses of multiple vasopressor)
CRRT
Indications:
Hemodynamically instability requiring 1or more inotropes at high doses and/or failure to tolerate IHD or SLED Catabolic state:
CRRT provides more optimal biochemical and metabolic control than IHD/SLED
SCUF
CVVH
Most popular removes large volumes of fluids and waste from the patient. It then uses replacement fluids (also known as a substitution solution), which are devoid of toxins, to maintain electrolyte and acid base balance. Dialysate is not used
Replacement fluids
Is used to replace any water that is removed during hemofiltration. Thus, it is able to prevent hypovolemia Any fluid removed during hemofiltration is given back to maintain a net neutral fluid balance Replacement fluid must be sterile intravenous fluids with concentrations of electrolytes similar to plasma.
CVVH
CVVH
Prescription based on Prisma CRRT machine algorithm: Qb: 150-220ml/min
A higher blood flow rate is needed if more intensive CVVH is performed
Predilution of the blood prior to its entry in the dialyzer with replacement fluid can lead to decreased requirement of anticoagulation and also by maintaining the concentration gradient Postdilution means that the replacement fluid is returned to the blood after the filter Postdilution concentrates the blood in the filter, enhancing clearance.
CVVHD
This type of therapy primarily uses diffusion along with a cleansing fluid known as a dialysate solution to boost the removal of waste products Continuous diffusive dialysis Mostly small molecules are removed
CVVHD
CVVHDF
With CVVHDF, large volumes of fluids and waste are removed from the patient. Cleansing fluids (dialysate solution) and replacement fluids (substitution solution) are used to replace the dirty plasma with clean fluid. This allows for the removal of large volumes of toxinfilled plasma, while still maintaining electrolyte balance.
CVVHDF
Removal of small molecules by diffusion through the addition of dialysate solution. Removal of middle to large molecules by convection through the addition of replacement solution.
CVVHDF
minimal Ultrafiltration
No
yes
no
Yes
no
no
yes
yes
Advantage
Less susceptible to e- disorder d/t dialysate replacement Can treat both volume overload + azotemia
Less susceptible to edisorder d/t dialysate replacement Allow mech to increase convection solute removal while performing HD Useful for volume expanded pt with high solute load
disadvantage
Not much solute clearance Slow bl flow rate prone to get system thrombosis
Vascular Access
A veno-venous double lumen hemodialysis catheter or two single lumen venous hemodialysis catheters may be used.
306100135
Access Location
Internal Jugular Vein
Primary site of choice due to lower associated risk of complication and simplicity of catheter insertion.
Femoral Vein
Patient immobilized, the femoral vein is optimal and constitutes the easiest site for insertion.
Subclavian Vein
The least preferred site given its higher risk of pneumo/hemothorax and its association with central venous stenosis.
306100135
The following are suggested guidelines for the different sites: RIJ= 15 cm French LIJ= 20 cm French Femoral= 25 cm French
306100135
COMPLICATIONS
Complications
Vascular access Vascular spasm(initial BFR too high) Movement of catheter against vessel wall Improper length of hemodialysis catheter inserted Fluid volume deficit Excessive fluid removal without appropriate fluid replenishment
306100135
Complications
Hypotension Intravascular volume depletion Underlying cardiac dysfunction Electrolyte imbalances High ultrafiltration rates (high clearance) Inadequate replenishment of electrolytes by intravenous infusion, Inadequate replenishment of bicarbonate loss during CRRT
306100135
Complications
Acid/base imbalance Blood loss Ineffective anticoagulation therapy Clotting of hemofilter Inadvertent disconnection in the CRRT system Hemorrhage due to over-anticoagulation Blood filter leaks
306100135
Complications
Air embolus Leaks or faulty connections in tubing Line separation. Cardiac arrest Hypotension/hypertension Air embolism Circulatory overload Arrhythmias
306100135
OTHER ISSUES
Other issues
Hypothermia Coagulation Blood loss during CRRT Nutritional support Changes in medications dosage in RRT
1)HYPOTHERMIA IN CRRT
Hypothermia
Causes
Patients blood in extracorporeal circuit at room temperature Administration of large volumes of room temperature fluids (replacement and dialysate)
Treatment
Warming blanket
306100135
2)COAGULATION IN CRRT
Blood contact to circuit tubing in CRRT leading to activation of coagulation cascade Result in clotting of filter or circuit Even the most biocompatible membranes gradually occluded by fibrin microthrombi
COAGULATION IN CRRT
Factors leading to clot formation
Poor or low flow rates through the dialyser circuit which is affected by vascular assess Areas of stagnant blood particularly where pumps join the circuit Air blood interfaces as in bubble traps ( the 1st sign of clotting usually occurs in the bubble trap and not the dialyzer) HCT plays a significant role in clotting of dialysis circuit and is exacerbated by high filtration rates Membrane material: till now, no membrane material is currently available that binds heparin permanently
COAGULATION IN CRRT
Anticoagulant therapy to prevent dialyzer clot formation
Most CRRT machines incorporate a pump that can infuse heparin into the dialyzer circuit b4 the blood pump is started
Doses btw 200 800 units per hour
Other anticoagulant:
LMWH, prostacyclin and sodium citrate
COAGULATION IN CRRT
If bleeding risk is high, the safest approach is no anticoagulant at all
Thus, saline flushing is used .
100ml of N/S is flushed thru the filter every hour to prevent clotting of dialysis circuit
4)Nutritional support
RRT can cause additional protein losses
CVVH 10 15g/day IHD : 6- 8 g/day
who?
CRRT
Why?
How?
Intermittent renal replacement To remove fluid, To remove fluid, electrolytes and Electrolytes and toxin slowly toxin rapidly Continuous Every 2 to 3 24hrs. days and last about 3 to 4 hrs. No yes
CRRT
Need to reduce Dosage of renal clearance drug Need to adjust administration times of renally cleared drugs Need to limit protein, KCL and fluid intake
Yes
No
Yes
CRRT
Yes